Hepatocellular carcinoma (HCC) is a significant global health concern, particularly in regions like the Asia-Pacific, where chronic viral hepatitis and liver diseases contribute to its high incidence ...

导语分子诊断在肝胆肿瘤临床诊断、方案制定、疗效评估和预后判断等各个方面应用广泛，相关研究不断推陈出新。在肝胆肿瘤临床诊疗中完善某种或多种分子检测，可能为患者提供疗效更好的治疗方案，从而延长患者的生存时间，改善生活质量。近期，《肝胆肿瘤分子诊断临床应用专家共识（2024 ...

It offers a non-invasive approach and has broad clinical relevance in cancer management. This comprehensive review primarily ...

Hepatocellular carcinoma (HCC) is one of the most fatal malignancies. Epigenetic mechanisms have revealed that noncoding RNAs ...

Carisma Therapeutics (CARM) announced the upcoming presentation of new pre-clinical data on its anti-GPC3 in vivo chimeric antigen receptor ...

In the quest to enhance the efficacy of chimeric antigen receptor T (CAR-T) cell therapy against hepatocellular carcinoma ...

Carisma Therapeutics Inc. (Nasdaq: CARM) ("Carisma" or the "Company"), a clinical-stage biopharmaceutical company focused on discovering and developing innovative immunotherapies, today announced ...

Carisma Therapeutics Inc. (Nasdaq: CARM) ("Carisma" or the "Company"), a clinical-stage biopharmaceutical company focused on discovering and developing innovative immunotherapies, today announced the ...